Cerity Partners LLC Abbott Laboratories Transaction History

Cerity Partners LLC

$37.7 Billion
Q2 2024

A detailed history of Cerity Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cerity Partners LLC holds 883,245 shares of ABT stock, worth $99.3 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

883,245

Previous 961,678 8.16%

Holding current value

$99.3 Million

Previous $109 Million 16.04%

% of portfolio

0.24%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $7.9 Million - $8.82 Million	-78,433 Reduced 8.16%	883,245 $91.8 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $11 Million - $12.2 Million	-100,641 Reduced 9.47%	961,678 $109 Million
Q4 2023 Jan 26, 2024	BUY	$90.19 - $110.4 $25.1 Million - $30.7 Million	278,477 Added 35.53%	1,062,319 $117 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $11.6 Million - $13.9 Million	-121,626 Reduced 13.43%	783,842 $75.9 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $2.68 Million - $2.99 Million	26,640 Added 3.03%	905,468 $98.7 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $20.5 Million - $24.2 Million	212,097 Added 31.81%	878,828 $89 Million
Q4 2022 Feb 15, 2023	BUY	$95.06 - $111.52 $46.8 Million - $54.9 Million	492,376 Added 282.4%	666,731 $73.2 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $50,411 - $58,367	-521 Reduced 0.3%	174,355 $16.9 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $7.87 Million - $9.52 Million	77,134 Added 78.92%	174,876 $19 Million
Q1 2022 Apr 25, 2022	SELL	$114.02 - $139.04 $691,303 - $842,999	-6,063 Reduced 5.84%	97,742 $10.9 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $3.34 Million - $4.09 Million	28,911 Added 38.6%	103,805 $13.7 Million
Q3 2021 Oct 25, 2021	SELL	$116.66 - $129.06 $504,904 - $558,571	-4,328 Reduced 5.46%	74,894 $8.85 Million
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $23,485 - $27,645	-222 Reduced 0.28%	79,222 $9.18 Million
Q1 2021 Aug 11, 2021	SELL	$108.84 - $128.23 $954,417 - $1.12 Million	-8,769 Reduced 9.94%	79,444 $9.52 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $134,852 - $158,876	-1,239 Reduced 1.39%	88,213 $10.6 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $534,345 - $582,283	5,089 Added 6.03%	89,452 $9.79 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $3.1 Million - $3.76 Million	33,803 Added 66.86%	84,363 $9.18 Million
Q2 2020 Aug 17, 2020	SELL	$76.57 - $98.0 $19,601 - $25,088	-256 Reduced 0.5%	50,560 $4.62 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $484,381 - $619,948	-6,326 Reduced 11.07%	50,816 $4.65 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $473,223 - $691,981	-7,533 Reduced 11.65%	57,142 $4.51 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $404,797 - $450,634	5,156 Added 8.66%	64,675 $5.62 Million
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $596,449 - $646,737	-7,288 Reduced 10.91%	59,519 $4.98 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $1.01 Million - $1.18 Million	-13,846 Reduced 17.17%	66,807 $5.62 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $779,939 - $942,946	-11,778 Reduced 12.74%	80,653 $6.45 Million
Q4 2018 Feb 06, 2019	BUY	$65.56 - $74.27 $560,275 - $634,711	8,546 Added 10.19%	92,431 $6.69 Million
Q3 2018 Nov 15, 2018	BUY	$60.81 - $73.36 $281,611 - $339,730	4,631 Added 5.84%	83,885 $6.15 Million
Q2 2018 Aug 15, 2018	BUY	$57.57 - $63.54 $763,838 - $843,048	13,268 Added 20.11%	79,254 $4.83 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $279,155 - $315,618	4,961 Added 8.13%	65,986 $3.95 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $22,545 - $24,137	420 Added 0.69%	61,025 $3.48 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $2.91 Million - $3.25 Million	60,605	60,605 $3.23 Million

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Abbott Laboratories Transaction History